This year was a year of firsts for catheter-based innovations, most notably for renal denervation and pulsed field ablation. ReCor Medical won an FDA panel nod for its renal denervation system in August. The panel voted in favor of the safety and efficacy of its Paradise ultrasound renal denervation (RDN) system for treating hypertension. The … [Read more...] about The 10 most-read catheter-based innovation stories of 2023
Alleviant Medical
Alleviant Medical raises $75M for no-implant heart failure treatment
Alleviant Medical has raised $75 million to support a global pivotal trial of its catheter-delivered interatrial shunt to treat heart failure. The FDA provided the Austin, Texas–based company with an Investigational Device Exemption for the clinical trial in November 2022. Researchers have designed the ALLAY-HF study to demonstrate the safety … [Read more...] about Alleviant Medical raises $75M for no-implant heart failure treatment
Alleviant Medical wins FDA breakthrough device designation for transcath heart failure treatment
Alleviant Medical (Austin, Texas) has received FDA breakthrough device designation for its no-implant, interatrial shunt technology for treating certain types of chronic heart failure. Founded in 2017, Alleviant's minimally invasive transcatheter tech decompresses the left atrium without a permanent cardiac implant or open-heart surgery. … [Read more...] about Alleviant Medical wins FDA breakthrough device designation for transcath heart failure treatment
